LexDanaLexDanabeta
Inventor

Orion D. Jankowski

Inventor
Burlingame, CA, US

Overview

21→
Patents
2003–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds23%
C07CAcyclic or carbocyclic compounds22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
A61KPreparations for medical, dental or toiletry purposes17%
C07BGeneral methods of organic chemistry9%
H01CResistors4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
10,968,1664-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases202110,167,2514-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases201910,071,978Process for the production of alpha-tocotrienol and derivatives20189,932,286Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers20189,546,132'4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases'20179,278,085'Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers'20169,169,196'4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases'20159,090,576'2-substituted-p-quinone derivatives for treatment of oxidative stress diseases'20159,073,873'2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases'20158,716,527'2-substituted-p-quinone derivatives for treatment of oxidative stress diseases'20148,716,486'2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases'20148,575,369'Process for the production of alpha-tocotrienol and derivatives'20138,519,001'4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases'20138,106,223'Process for the production of alpha-tocotrienol and derivatives'20128,067,395'Inhibitors of tyrosine kinases and uses thereof'20117,968,746'4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases'20117,625,880'Inhibitors of tyrosine kinases and uses thereof'20097,151,116'Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells'20066,987,440'Electrical devices containing conductive polymers'20066,593,843'Electrical devices containing conductive polymers'20036,531,950'Electrical devices containing conductive polymers'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2006Based in Stanford, CA, US· patent location history
2006–2021Based in Burlingame, CA, US· patent location history
2011–2017Patents assigned to EDISON PHARMACEUTICALS INC (11)· patent assignee history
2011–2016Patents assigned to JANKOWSKI ORION D (7)· patent assignee history
2012–2016Patents assigned to WESSON KIERON E (6)· patent assignee history
2012–2014Patents assigned to HINMAN ANDREW W (4)· patent assignee history
2018–2019Patents assigned to BIOELECTRON TECH CORP (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
EDISON PHARMACEUTICALS INC112011–2017
JANKOWSKI ORION Dself72011–2016
WESSON KIERON E62012–2016
HINMAN ANDREW W42012–2014
BIOELECTRON TECH CORP32018–2019
Locations
LocationPatentsSpan
Burlingame, California, US182006–2021
Stanford, California, US32003–2006